HomeORGANIZATION
ORGANIZATION

Annual Price Revisions Will Demotivate Pharmas, Foreign HQs Harboring Serious Concerns: PhRMA Japan Chief
(Dec.9.2016)

Patrik Jonsson, Chairman of PhRMA Japan-based Executive Committee
A proposal to revise drug prices annually, which now looms as a real possibility, will demotivate drug makers to develop innovative drugs for Japan, and significantly erode the market’s attractiveness, Patrik Jonsson, chairman of the Japan-based Executive Committee at PhRMA, told Jiho ...
(LOG IN FOR FULL STORY)

News Calendar